Literature DB >> 8475085

Role of nitric oxide in interleukin 2-induced corticotropin-releasing factor release from incubated hypothalami.

S Karanth1, K Lyson, S M McCann.   

Abstract

Stimulation of corticotropin-releasing factor (CRF) release from the hypothalamus by interleukin 2 (IL-2) was recently demonstrated. Cytokines induce nitric oxide synthase (NOS), an enzyme that converts L-arginine into L-citrulline and nitric oxide (NO). NO is believed to be responsible for the cytotoxic action of these agents. The constitutive form of NOS occurs in neurons in the central nervous system and NO appears to play a neurotransmitter role in cerebellar and hippocampal function. We explored the probability that IL-2 and synaptic transmitters might release CRF via NO. The effects of L-arginine, the substrate for NOS, and NG-monomethyl-L-arginine (NMMA), a competitive inhibitor of NOS, on IL-2-induced CRF release were studied using mediobasal hypothalami (MBHs) incubated in vitro in Krebs-Ringer bicarbonate buffer. L-Arginine did not alter basal and IL-2-induced CRF release after 30 min of incubation but significantly elevated both basal and IL-2-induced CRF release when MBHs were incubated 30 min longer, presumably because the endogenous substrate had been depleted after the initial 30-min incubation period. In 30-min incubations, both carbachol, an acetylcholineomimetic drug, and norepinephrine stimulated CRF release. There was an additive effect of incubation of the MBHs in the presence of carbachol (10(-7) M) and IL-2 (10(-13) M). On the other hand, coincubation of MBHs with norepinephrine (10(-6) M) and IL-2 (10(-13) M) did not produce any additive effect. Addition of NMMA, an inhibitor of NOS, at 1 or 3 x 10(-4) M completely suppressed IL-2-induced release of CRF as well as that caused by IL-2 plus carbachol. In contrast, the release of CRF induced by norepinephrine was not blocked by 3 x 10(-4) M NMMA. The data indicate that IL-2 can activate constitutive NOS leading to increased NO release, which activates CRF release. It appears that NO is also involved in the release of CRF induced by carbachol but not by norepinephrine.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8475085      PMCID: PMC46304          DOI: 10.1073/pnas.90.8.3383

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  18 in total

1.  Endothelial cell production of nitrogen oxides in response to interferon gamma in combination with tumor necrosis factor, interleukin-1, or endotoxin.

Authors:  R G Kilbourn; P Belloni
Journal:  J Natl Cancer Inst       Date:  1990-05-02       Impact factor: 13.506

2.  Neurotransmitter regulation of corticotropin-releasing factor in vitro.

Authors:  M T Jones; E W Hillhouse
Journal:  Ann N Y Acad Sci       Date:  1977-10-28       Impact factor: 5.691

3.  Facilitation of immunoreactive corticotropin-releasing factor secretion into the hypophysial-portal circulation after activation of catecholaminergic pathways or central norepinephrine injection.

Authors:  P M Plotsky
Journal:  Endocrinology       Date:  1987-09       Impact factor: 4.736

4.  Interleukin-2 induces corticotropin-releasing hormone release from superfused rat hypothalami: influence of glucocorticoids.

Authors:  J C Cambronero; F J Rivas; J Borrell; C Guaza
Journal:  Endocrinology       Date:  1992-08       Impact factor: 4.736

5.  Interleukin 2 modifies the bioelectric activity of some neurosecretory nuclei in the rat hypothalamus.

Authors:  M Bindoni; V Perciavalle; S Berretta; N Belluardo; T Diamantstein
Journal:  Brain Res       Date:  1988-10-11       Impact factor: 3.252

6.  Corticotropin-releasing factor release from in vitro superfused and incubated rat hypothalamus. Effect of potassium, norepinephrine, and dopamine.

Authors:  P Joanny; J Steinberg; A J Zamora; B Conte-Devolx; Y Millet; C Oliver
Journal:  Peptides       Date:  1989 Sep-Oct       Impact factor: 3.750

7.  Nitric oxide mediates norepinephrine-induced prostaglandin E2 release from the hypothalamus.

Authors:  V Rettori; M Gimeno; K Lyson; S M McCann
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-01       Impact factor: 11.205

8.  Effect of cholinergic agonists and antagonists on rat hypothalamic corticotropin-releasing hormone secretion in vitro.

Authors:  A E Calogero; W T Gallucci; R Bernardini; C Saoutis; P W Gold; G P Chrousos
Journal:  Neuroendocrinology       Date:  1988-04       Impact factor: 4.914

9.  Acetylcholine and norepinephrine stimulate the release of corticotropin-releasing factor-41 from the rat hypothalamus in vitro.

Authors:  S Tsagarakis; J M Holly; L H Rees; G M Besser; A Grossman
Journal:  Endocrinology       Date:  1988-10       Impact factor: 4.736

10.  Localization of interleukin-2 immunoreactivity and interleukin-2 receptors in the rat brain: interaction with the cholinergic system.

Authors:  D M Araujo; P A Lapchak; B Collier; R Quirion
Journal:  Brain Res       Date:  1989-10-02       Impact factor: 3.252

View more
  23 in total

1.  Oral administration of a corticotropin-releasing hormone receptor antagonist significantly attenuates behavioral, neuroendocrine, and autonomic responses to stress in primates.

Authors:  K E Habib; K P Weld; K C Rice; J Pushkas; M Champoux; S Listwak; E L Webster; A J Atkinson; J Schulkin; C Contoreggi; G P Chrousos; S M McCann; S J Suomi; J D Higley; P W Gold
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

2.  Estrogen downregulates neuronal nitric oxide synthase in rat anterior pituitary cells and GH3 tumors.

Authors:  X Qian; L Jin; R V Lloyd
Journal:  Endocrine       Date:  1999-10       Impact factor: 3.633

Review 3.  Pass the nitric oxide.

Authors:  D V Madison
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-15       Impact factor: 11.205

Review 4.  Role of nitric oxide in cluster headache.

Authors:  Anna Steinberg; A Ingela M Nilsson Remahl
Journal:  Curr Pain Headache Rep       Date:  2012-04

5.  Ascorbic acid acts as an inhibitory transmitter in the hypothalamus to inhibit stimulated luteinizing hormone-releasing hormone release by scavenging nitric oxide.

Authors:  S Karanth; W H Yu; A Walczewska; C Mastronardi; S M McCann
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-15       Impact factor: 11.205

Review 6.  Immortalized hypothalamic luteinizing hormone-releasing hormone (LHRH) neurons: a new tool for dissecting the molecular and cellular basis of LHRH physiology.

Authors:  W C Wetsel
Journal:  Cell Mol Neurobiol       Date:  1995-02       Impact factor: 5.046

7.  Growth hormone-releasing hormone and gonadotropin-releasing hormone stimulate nitric oxide production in 17beta-estradiol-primed rat anterior pituitary cells.

Authors:  Michihiro Tsumori; Yoshio Murakami; Kunio Koshimura; Yuzuru Kato
Journal:  Endocrine       Date:  2002-04       Impact factor: 3.633

8.  Role of nitric oxide in the control of luteinizing hormone-releasing hormone release in vivo and in vitro.

Authors:  V Rettori; N Belova; W L Dees; C L Nyberg; M Gimeno; S M McCann
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-01       Impact factor: 11.205

9.  Nitric oxide inhibits hypothalamic luteinizing hormone-releasing hormone release by releasing gamma-aminobutyric acid.

Authors:  A Seilicovich; B H Duvilanski; D Pisera; S Theas; M Gimeno; V Rettori; S M McCann
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-11       Impact factor: 11.205

10.  Colocalization of cannabinoid receptor 1 with somatostatin and neuronal nitric oxide synthase in rat brain hypothalamus.

Authors:  Shenglong Zou; Rishi K Somvanshi; Seungil Paik; Ujendra Kumar
Journal:  J Mol Neurosci       Date:  2014-07-08       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.